PRKAB1 and cancer: We observe that PHLPP2 also targets phospho-AMPK in solid tumor-derived cancer lines (Fig. 1F), although differences in the impact of PHLPP2 loss on their responses to glucose limitation (Fig. S3) suggest different roles for AMPK in the cell lines.